Publications by authors named "Susan Robson"

Claim this Profile
A
An Industry Perspective on Compassionate Use in Europe: A Call for Change.
Philipp Schlatter, Nina Heiss, Pedro Franco, Annie O'Keefe Martin, Susan Robson

Ther Innov Regul Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study.
Jan Astermark, Susanna Ranta, Linda Myrin-Westesson, Marianne Hoffmann, Sandrine Quere, Susan Robson

Haemophilia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Experience from the STASEY Study of Emicizumab Prophylaxis in People with Hemophilia A with Factor VIII Inhibitors.
Giancarlo Castaman, Flora Peyvandi, Johanna A Kremer Hovinga, Roger E G Schutgens, Susan Robson

TH Open· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of long-term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single-arm study (STASEY).
Víctor Jiménez-Yuste, Flora Peyvandi, Robert Klamroth, Giancarlo Castaman, Chandrakala Shanmukhaiah, Susan Robson

Res Pract Thromb Haemost· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study.
Simon Rule, Wolney Gois Barreto, Javier Briones, Angelo M Carella, Olivier Casasnovas, Susan Robson

Haematologica· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study.
Francesc Bosch, Guy Cantin, Agostino Cortelezzi, Wolfgang Knauf, Mourad Tiab, Susan Robson

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everybody should have access to occupational health services.
Anne Raynal, Robert Hermanns, Susan Robson, Mark Weir, Daniel Carry

BMJ· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study.
Véronique Leblond, Melih Aktan, Christelle M Ferra Coll, Caroline Dartigeas, Jens Kisro, Susan Robson

Haematologica· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study.
Stephan Stilgenbauer, Veronique Leblond, Robin Foà, Sebastian Böttcher, Osman Ilhan, Susan Robson

Leukemia· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAF mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.
Christian U Blank, James Larkin, Ana M Arance, Axel Hauschild, Paola Queirolo, Susan Robson

Eur J Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping dominant annual land cover from 2009 to 2013 across Victoria, Australia using satellite imagery.
Kathryn Sheffield, Elizabeth Morse-McNabb, Rob Clark, Susan Robson, Hayden Lewis

Sci Data· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VLUIS, a land use data product for Victoria, Australia, covering 2006 to 2013.
Elizabeth Morse-McNabb, Kathryn Sheffield, Rob Clark, Hayden Lewis, Susan Robson

Sci Data· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation.
Jean-Noel Hugues, David H Barlow, Zev Rosenwaks, Isabelle Cédrin-Durnerin, Susan Robson

Reprod Biomed Online· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis